Innovation in cancer treatment comes at a cost
The Institute for Value-Based Medicine® will host an event focused on innovative cancer treatments and the challenges that come with them, with Dr. Co-chaired by Ryan Haumschild and Jonathan Kaufman, MA, MBA, CPEL. M.D., professor of hematology and medical oncology at Emory University School of Medicine and board-certified medical oncologist at Emory University Hospital. At this event, clinicians will discuss important topics including health equity in breast cancer, perioperative treatment of non-small cell lung cancer (NSCLC), and evolving treatments for advanced lymphoma and renal cell carcinoma (RCC). It was characterized by Presenters highlighted persistent racial disparities in breast cancer treatment, particularly impacting Black and Native American women. We investigated new perioperative strategies in NSCLC. We then discussed the cost-effectiveness of new lymphoma treatments. Discussions at the RCC centered on the need for better tools to measure recurrence risk and manage treatment toxicity, but balancing innovation and patient quality of life across cancer remains a challenge. This is a central issue.
Dr. Maxine Dexter: Physician voices are critical to public health
At the CHEST 2024 Annual Meeting in Boston, Kaiser Permanente Pulmonary and Critical Care Physician Maxine Dexter, M.D., spoke about her presentation, “Prescribing “Change: Redefining the Role of Physicians in Public Health Advocacy.” ®. Dexter, who will serve as a congressman after serving in the Oregon House of Representatives, emphasizes the important role that physicians play in shaping public policy, particularly in addressing health crises such as the opioid epidemic and environmental issues such as air pollution. did. She draws on her medical background to emphasize the importance of evidence-based law, share examples of how health policy and social policy intersect, and provide doctors with first-hand experience with patients from diverse backgrounds. He pointed out that this allows us to understand the impact that public health has on broader society. assignment.
Addressing psychosocial needs and addressing financial toxicity received attention at ACCC
At the Association of Cancer Care Centers (ACCC) 41st National Oncology Congress, economic toxicity and navigation were key discussion points, highlighting their significant impact on cancer patients and healthcare providers. Presenters from the Cancer Support Community and Highlands Oncology Group highlighted how economic burdens, especially for ethnic minorities and rural areas, exacerbate care access challenges. Research by the Cancer Support Community highlights the need for culturally competent care, points to distrust in the health care system, and the importance of social and emotional support in patient resilience. Meanwhile, Highlands Oncology Group showcased the success of its financial navigation program, enhanced through a partnership with TailorMed. The program combined technology and human resources to improve patient support, streamline processes, and reduce staff burnout.
Why are there still gaps in cardiac care for women?
Women have historically been underrepresented in cardiovascular clinical trials, creating gaps in our understanding of how heart disease affects men differently. This disparity was further exacerbated by 1977 FDA guidelines that prevented women of childbearing age from participating in clinical trials. Efforts to increase women’s representation began in the 1990s, but large gaps remain. A review of heart failure trials showed that only 26% of participants were women, and female involvement in cardiovascular research is generally still less than 50%. Dr Kathryn Lindley highlights the need for a multi-pronged approach, including better access to clinical trials and education for clinicians, and empowering women to advocate for themselves to address this deep-rooted issue. Masu.
Data shows undocumented Latinos face disproportionate burden of long-term COVID-19 infections
Recent research shows that undocumented Latino immigrants, who make up 7% of the U.S. population, face significant barriers to health care, including high uninsured rates, limited access to primary care, and concerns related to their immigration status. It became clear. Additionally, undocumented Latino immigrants are the most likely to miss work or school due to long-term COVID-19 symptoms (57.1%) and have the least access to care, with 60% not receiving treatment. Ta. Extensive study of excess mortality during the COVID-19 pandemic highlights disparities with non-Hispanic American Indian/Alaska Native and Hispanic populations experiencing the highest mortality rates and potential years of life lost It became. These findings highlight the need for improved culturally relevant health care resources and infrastructure to protect vulnerable groups.
